Author:
Kiltz Uta,Legeler Carolin,Maier-Peuschel Monika,Mann Christian,Tony Hans-Peter
Abstract
Objective:
AQUILA is an ongoing, multicenter, prospective, Non-Interventional Study (NIS) with secukinumab, designed to evaluate real-world evidence for different aspects of treatment in patients with Ankylosing Spondylitis (AS) and psoriatic arthritis (PsA) in Germany. Here we report the study design and baseline characteristics including comorbidities and prior medication of patients as well as insights into medical care in Germany.
Methods:
Patients (age ≥18 years) with active AS or PsA, who were under secukinumab treatment or just about initiating secukinumab therapy based on medical therapeutic need,
are
enrolled. Each patient
is
observed for 52 weeks.
Results:
A total of 572 patients (AS, n = 187; PsA, n = 385) have been recruited in this ongoing study. Mean age, weight, and BMI were similar between the subgroups. About 66.4% of patients had previously received biologics other than secukinumab. Depression was the most common comorbidity (AS, 9.1%; PsA, 15.6%). Plaque psoriasis was also frequently reported (AS, 9.6%; PsA, 62.3%).
Conclusion:
The Non-Interventional Study (NIS) baseline characteristics indicate that the demographics were similar to populations of previous secukinumab trials of AS and PsA patients except
to
comorbidities and exposure to biologics. A majority of the patients who received secukinumab in this setting had previously received biologics. Comorbidities relating to obesity and cardiovascular disease were particularly evident in PsA patients whereas the elevated depression prevalence was equally distributed.
Publisher
Bentham Science Publishers Ltd.
Reference39 articles.
1. Braun J, Sieper J.
Ankylosing spondylitis.
Lancet
2007;
369
(9570)
: 1379-90.
2. Gladman DD, Antoni C, Mease P, Clegg DO, Nash P.
Psoriatic arthritis: epidemiology, clinical features, course, and outcome.
Ann Rheum Dis
2005;
64
(Suppl. 2)
: ii14-7.
3. Kiltz U, van der Heijde D.
Health-related quality of life in patients with rheumatoid arthritis and in patients with ankylosing spondylitis.
Clin Exp Rheumatol
2009;
27
(4)
(Suppl. 55)
: S108-11.
4. Tam LS, Gu J, Yu D.
Pathogenesis of ankylosing spondylitis.
Nat Rev Rheumatol
2010;
6
(7)
: 399-405.
5. Boonen A, van der Linden SM.
The burden of ankylosing spondylitis.
J Rheumatol Suppl
2006;
78
: 4-11.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献